About Onyx Biotec
Onyx Biotec is a company based in Solan (India) founded in 2009. The company has 227 employees as of July 20, 2024. Onyx Biotec offers products and services including Water for Injection, Dry Powder Injections, and Dry Powder Syrup. Onyx Biotec operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Solan, India
- Employees 227 as on 20 Jul, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Onyx Biotec Ltd.
-
Annual Revenue
$7.25 M (USD)15.26as on Mar 31, 2025
-
Net Profit
$579.87 K (USD)63.42as on Mar 31, 2025
-
EBITDA
$1.21 M (USD)24.06as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
227
as on Jul 20, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Onyx Biotec
Onyx Biotec is a publicly listed company on the NSE with ticker symbol ONYX in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Onyx Biotec
Onyx Biotec offers a comprehensive portfolio of products and services, including Water for Injection, Dry Powder Injections, and Dry Powder Syrup.
Sterile water for preparing injections in medical treatments.
Antibiotic powders for reconstitution and injection use.
Powder for oral suspension to treat illnesses in patients.
Funding Insights of Onyx Biotec
Detailed funding history for Onyx Biotec
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Onyx Biotec
Investment portfolio details for Onyx Biotec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Onyx Biotec
Detailed financials for Onyx Biotec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Onyx Biotec Comparisons
Peer comparison for Onyx Biotec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Onyx Biotec
Onyx Biotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Onyx Biotec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Onyx Biotec
Complete news archive for Onyx Biotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Onyx Biotec
Onyx Biotec was founded in 2009.
Onyx Biotec is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.
As of Jul 20, 2024, the latest employee count at Onyx Biotec is 227.
Annual revenue of Onyx Biotec is $7.25M as on Mar 31, 2025.
Onyx Biotec Ltd. is a pharmaceutical company that manufactures and distributes generic and proprietary pharmaceutical products. The company is committed to good corporate governance practices and has a strong presence in the Indian pharmaceutical market. With a focus on quality and customer satisfaction, Onyx Biotec Ltd. aims to be a leading player in the industry.
Onyx Biotec's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Onyx Biotec offers Water for Injection, Dry Powder Injections, and Dry Powder Syrup.
Yes, Onyx Biotec is publicly traded on NSE under the ticker symbol ONYX.
The ticker symbol of Onyx Biotec is ONYX on NSE.